Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Crunching Some Numbers and What They Say – Part I

This is one of those articles that are packed with resources showing your what to expect for various assets both long-term and short-term and will guide you through these volatile times and this year. Our friends and followers continue to contact us asking what to expect a...
Chris Vermeulen | March 16, 2020 |

You’re Probably Underinvested in Gold

In a September report, the World Gold Council (WGC) pointed out that some investors are underexposed to gold. The gist of the study is that investors may assume they have adequate exposure to gold because they’re invested in a fund that tracks a broad-ba...
Frank Holmes | November 4, 2019 |

Time to Replace Bonds with Gold in Your Portfolio?

Recently, the WGC published a fresh Investment Update entitled It may be time to replace bonds with gold . Is it? According to the report, investors are now facing the environment with flat to inverted yield curves , stock valuations at extreme levels that historical...
Arkadiusz Sieron | November 12, 2019 |

Johnson & Johnson, Memphasys, Procter & Gamble - for a better life

Good health is a valuable possession. Small and large companies around the globe are engaged in research and development to make people's lives easier or better through modern and innovative products and solutions. The consumer goods and pharmaceutical sectors often offer attr...
Mario Hose | April 16, 2020 |

Lufthansa, Osino Resources, Wirecard - exciting opportunities for investors

Social life has changed by 180 degrees since February 2020 with the spread of the Corona Virus Covid-19. Business people spend more time in video conferences than on planes, trains or cars. The time spent in the office is often minimized and work is done from home instead. Fam...
Mario Hose | April 23, 2020 |

Buzz on the Bullboards: TSX struggles, interest rates, U.S. volatility

This week has been challenging for the TSX , which had seen a downturn after reaching new highs last week. The market’s performance has been influenced by the Bank of Canada’s decision to cut its benchmark interest rate by 50 basis points,...
Jonathon Brown | October 24, 2024 |

Buzz on the Bullboards: In Volatile Times, These Companies Make Headlines

(Image via Canopy Growth Corp.) It has been another tumultuous week on Bay St. and Wall St. with investors busy keeping tabs on which way the markets are heading … trajectories change on what seems like a moment’s notice. Weaker metal prices have...
Stockhouse Editorial | January 26, 2022 |

Coverage Initiated on Company 'Combining Active 3D Data/Imaging and AI to Avert Security Threats'

The highlights of the U.S. firm and its product are presented in a Laurentian Bank Securities report. In a Sept. 10 research note, analyst Nick Agostino reported that Laurentian Bank Securities initiated coverage on Liberty Defense Holdings Ltd. (SCAN:TSX.V; LDDFF:OT...
Streetwise Reports | September 12, 2019 |

Sanofi Pays Lexicon Pharma $260 Million to Settle Diabetes Drug Dispute

Lexicon Pharmaceuticals shares traded higher by more than 30% today after the company announced termination of its alliance with Sanofi SA and a $260 million settlement over its diabetes drug Zynquista. Yesterday afternoon, The Woodlands, Tex.-based Lexicon Pharmaceu...
Streetwise Reports | September 12, 2019 |

Phase 2 Data from Potential Multibagger Biopharma 'Checks All the Boxes'

The latest clinical trial results are dissected in a ROTH Capital Partners report. In a Sept. 26 research note, ROTH Capital Partners analyst Jerry Isaacson reported that AzurRx BioPharma Inc.'s (AZRX:NASDAQ) Phase 2 OPTION trial for lead candidate MS1819 in cystic ...
Streetwise Reports | October 1, 2019 |
1 2 3 4 5